Literature DB >> 3922431

The removal of carbohydrates from ricin with endoglycosidases H, F and D and alpha-mannosidase.

B M Foxwell, T A Donovan, P E Thorpe, G Wilson.   

Abstract

Recently, several investigators have explored the possibility of targeting ricin to designated cell types in animals by its linkage to specific antibodies. There is evidence, however, that the mannose-containing oligosaccharide chains on ricin are recognised by reticuloendothelial cells in the liver and spleen and so cause the immunotoxins to be removed rapidly from the blood stream. In the present study we analysed the carbohydrate composition of ricin and examined enzymic methods for removing the carbohydrate. The carbohydrate analysis ricin A-chain revealed the presence of one residue of xylose and one of fucose in addition to mannose and N-acetylglucosamine which had been detected previously. The B-chain contained only mannose and N-acetylglycosamine. Ricin A-chain is heterogeneous containing two components of molecular weight 30 000 and 32 000. Strong evidence was found that the heavier form of the A-chain contains an extra carbohydrate unit which is heterogeneous with respect to concanavalin A binding and sensitivity to endoglycosidase H. The lower molecular weight form of A-chain did not bind concanavalin A and was insusceptible to endoglycosidases. Only one of the two high mannose oligosaccharide units on the isolated B-chain could be removed by endoglycosidases H or F, whereas both were removable after denaturation of the polypeptide by SDS. Both the isolated A- and B-chains were sensitive to alpha-mannosidase. Intact ricin was resistant to endoglycosidase treatment and was only slightly sensitive to alpha-mannosidase. The addition of SDS allowed endoglycosidase H to remove both of the B-chain oligosaccharides from intact ricin and increased the toxin's sensitivity to alpha-mannosidase. In conclusion, extensive enzymic deglycosylation of ricin may only be possible if the A- and B-chains are first separated, treated with enzymes and then recombined to form the toxin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922431     DOI: 10.1016/0304-4165(85)90119-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Targeted kill: from umbrellas to monoclonal antibodies.

Authors:  V S Byers; R W Baldwin
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

2.  The generation and characterization of a rat neural cell line overexpressing the alpha2,6(N) sialyltransferase.

Authors:  K C Breen; A Potratz; N Georgopoulou; K Sandhoff
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

3.  Distribution of ricin within the mammalian para-aortic lymph node. II. Comparison of the localization, after intramuscular dosage of colloidal gold-labelled ricin in vivo, with in vitro binding characteristics of the native toxin.

Authors:  G D Griffiths; A G Leith; M D Leek; M A Green
Journal:  Histochem J       Date:  1989-07

Review 4.  N-glycosylation/deglycosylation as a mechanism for the post-translational modification/remodification of proteins.

Authors:  T Suzuki; K Kitajima; S Inoue; Y Inoue
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

5.  Comparative studies on kinetics of inhibition of protein synthesis in intact cells by ricin and a conjugate of ricin B-chain with momordin.

Authors:  S Sharma; S K Podder; A A Karande
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

6.  Comparative glycoproteomics of stem cells identifies new players in ricin toxicity.

Authors:  Johannes Stadlmann; Jasmin Taubenschmid; Daniel Wenzel; Anna Gattinger; Gerhard Dürnberger; Frederico Dusberger; Ulrich Elling; Lukas Mach; Karl Mechtler; Josef M Penninger
Journal:  Nature       Date:  2017-09-20       Impact factor: 49.962

7.  Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells.

Authors:  S Magnússon; T Berg
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Mechanism of the specific neuronal toxicity of a type I ribosome-inactivating protein, trichosanthin.

Authors:  Ou Sha; David Tai-Wai Yew; Eric Yu-Pang Cho; Tzi-Bun Ng; Lin Yuan; Wing-Hang Kwong
Journal:  Neurotox Res       Date:  2009-10-23       Impact factor: 3.911

9.  A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies.

Authors:  A Bolognesi; P L Tazzari; C Tassi; G Gromo; M Gobbi; F Stirpe
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 10.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.